$60 Million Pledged to Fast-Track Ebola Vaccines

An Ebola outbreak in the DRC in May has caused 291 confirmed cases, hundreds of suspected cases, and 43 confirmed deaths.

A nurse prepares a vaccine during an Ebola vaccine trial in Kampala, Uganda, on Feb. 3, 2025. Badru Katumba/AFP via Getty Images

A global health organization said on June 1 that it is pledging about $60 million to accelerate the development of three vaccine candidates against the Bundibugyo ebolavirus, which is causing the Ebola outbreak growing in central Africa.

The Coalition for Epidemic Preparedness Innovations (CEPI), an early investor in Moderna’s COVID-19 vaccine, will provide Moderna with about $50 million for preclinical testing and Phase 1 human trials of the company’s Ebola vaccine.